Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) surged 40 percent after a study said a combination of two of the company’s drugs shows promise for treating cystic fibrosis. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock performance was 40.41% in last session and finished the day at $93.53. Traded volume was 25.24million shares in the last session and the average volume of the stock remained 1.58million shares. The beta of the … Continue reading Top Gainers: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), XG Technology (NASDAQ:XGTI), Neurometrix (NASDAQ:NURO), CorMedix (NYSEMKT:CRMD), Doral Financial (NYSE:DRL)